EDAP TMS S.A. Stock Statistics NASDAQ:EDAP
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior. Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average. Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
|2022-10-19 - 2022-12-02||BUY||37.02|
|2022-10-13 - 2022-10-19||SELL||2.72|
|2022-10-11 - 2022-10-13||HOLD||0.434|
|2022-10-06 - 2022-10-11||SELL||-0.0620|
|2022-10-05 - 2022-10-06||HOLD||0.749|
Stock Score Effectiveness
Bollinger Stock Signal Effectiveness
Macd Signal Effectiveness
Mv7 Signal Effectiveness
Bollinger Signal Statistics
MV signal statistics
MACD Signal Statistics
About EDAP TMS S.A.
EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. It operates in three segments: High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST). The HIFU segment develops, manufactures, and ma... EDAP Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.